10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2019 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 21, 2020) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Net Sales | $ 31,904 | 30,578 | 27,390 |
| Cost of products sold, excluding amortization of intangible assets | 13,231 | 12,706 | 12,409 |
| Amortization of intangible assets | 1,936 | 2,178 | 1,975 |
| Research and development | 2,440 | 2,300 | 2,260 |
| Selling, general and administrative | 9,765 | 9,744 | 9,182 |
| Total Operating Cost and Expenses | 27,372 | 26,928 | 25,826 |
| Operating Earnings | 4,532 | 3,650 | 1,564 |
| Interest expense | 670 | 826 | 904 |
| Interest income | (94) | (105) | (124) |
| Net foreign exchange (gain) loss | 7 | 28 | (34) |
| Debt extinguishment costs | 63 | 167 | |
| Other (income) expense, net | (191) | (139) | (1,413) |
| Earnings from Continuing Operations Before Taxes | 4,077 | 2,873 | 2,231 |
| Taxes on Earnings from Continuing Operations | 390 | 539 | 1,878 |
| Earnings from Continuing Operations | 3,687 | 2,334 | 353 |
| Net Earnings from Discontinued Operations, net of taxes | 34 | 124 | |
| Net Earnings | 3,687 | 2,368 | 477 |
| Basic Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 2.07 | 1.32 | 0.20 |
| Discontinued Operations (in dollars per share) | 0.02 | 0.07 | |
| Net Earnings (in dollars per share) | 2.07 | 1.34 | 0.27 |
| Diluted Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 2.06 | 1.31 | 0.20 |
| Discontinued Operations (in dollars per share) | 0.02 | 0.07 | |
| Net Earnings (in dollars per share) | 2.06 | 1.33 | 0.27 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,768 | 1,758 | 1,740 |
| Dilutive Common Stock Options (in shares) | 13 | 12 | 9 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,781 | 1,770 | 1,749 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 61 | ||
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |